Literature DB >> 30413394

Baclofen for the treatment of alcohol use disorder: the Cagliari Statement.

Roberta Agabio1, Julia Ma Sinclair2, Giovanni Addolorato3, Henri-Jean Aubin4, Esther M Beraha5, Fabio Caputo6, Jonathan D Chick7, Patrick de La Selle8, Nicolas Franchitto9, James C Garbutt10, Paul S Haber11, Mathis Heydtmann12, Philippe Jaury13, Anne R Lingford-Hughes14, Kirsten C Morley15, Christian A Müller16, Lynn Owens17, Adam Pastor18, Louise M Paterson14, Fanny Pélissier19, Benjamin Rolland20, Amanda Stafford21, Andrew Thompson17, Wim van den Brink22, Renaud de Beaurepaire23, Lorenzo Leggio24.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30413394     DOI： 10.1016/S2215-0366(18)30303-1

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  26 in total

Review 1.  The ventral pallidum and relapse in alcohol seeking.

Authors:  Asheeta A Prasad; Gavan P McNally
Journal:  Br J Pharmacol       Date:  2020-07-09       Impact factor: 8.739

Review 2.  Pharmacogenetics of alcohol use disorder treatments: an update.

Authors:  Emily E Hartwell; Henry R Kranzler
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-06-11       Impact factor: 4.481

Review 3.  Prospects for pharmacotherapies to treat alcohol use disorder: an update on recent human studies.

Authors:  Mehdi Farokhnia; Brittney D Browning; Lorenzo Leggio
Journal:  Curr Opin Psychiatry       Date:  2019-07       Impact factor: 4.741

Review 4.  Treating Alcohol Use Disorder in Chronic Liver Disease.

Authors:  Eric R Yoo; George Cholankeril; Aijaz Ahmed
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-03-26

5.  Reduced motor cortex GABABR function following chronic alcohol exposure.

Authors:  Shi-Yu Peng; Zhe Shi; Dong-Sheng Zhou; Xin-Yue Wang; Xing-Xing Li; Xiao-Li Liu; Wei-Di Wang; Guan-Ning Lin; Bing-Xing Pan; Valerie Voon; Anthony A Grace; Markus Heilig; Ma-Li Wong; Ti-Fei Yuan
Journal:  Mol Psychiatry       Date:  2021-01-11       Impact factor: 15.992

6.  Baclofen attenuates fMRI alcohol cue reactivity in treatment-seeking alcohol dependent individuals.

Authors:  Warren B Logge; Richard W Morris; Andrew J Baillie; Paul S Haber; Kirsten C Morley
Journal:  Psychopharmacology (Berl)       Date:  2019-02-20       Impact factor: 4.530

Review 7.  Potential of GABAB Receptor Positive Allosteric Modulators in the Treatment of Alcohol Use Disorder.

Authors:  Paola Maccioni; Giancarlo Colombo
Journal:  CNS Drugs       Date:  2019-02       Impact factor: 5.749

Review 8.  The Use of Functional Magnetic Resonance Imaging to Test Pharmacotherapies for Alcohol Use Disorder: A Systematic Review.

Authors:  Erica N Grodin; Lara A Ray
Journal:  Alcohol Clin Exp Res       Date:  2019-08-23       Impact factor: 3.455

Review 9.  GABAB Receptors and Alcohol Use Disorders: Clinical Studies.

Authors:  Warren B Logge; Kirsten C Morley; Paul S Haber
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 10.  GABAB Receptor Chemistry and Pharmacology: Agonists, Antagonists, and Allosteric Modulators.

Authors:  A Nieto; T Bailey; K Kaczanowska; P McDonald
Journal:  Curr Top Behav Neurosci       Date:  2022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.